z-logo
open-access-imgOpen Access
Case of relapsed AIDS-related plasmablastic lymphoma treated with autologous stem cell transplantation and highly active antiretroviral therapy
Author(s) -
Hiroki Goto,
Shotaro Hagiwara,
Risen Hirai,
T. Miyama,
Haruhito Honda,
Amane Tagashira,
Toshihiko Iizuka,
Makoto Mochizuki,
Katsuji Teruya,
Yoshimi Kikuchi,
Shinichi Oka,
Akiyoshi Miwa
Publication year - 2011
Publication title -
rare tumors
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.285
H-Index - 15
eISSN - 2036-3613
pISSN - 2036-3605
DOI - 10.4081/rt.2011.e11
Subject(s) - medicine , plasmablastic lymphoma , etoposide , salvage therapy , transplantation , lymphoma , autologous stem cell transplantation , stem cell , surgery , melphalan , malignancy , regimen , hematopoietic stem cell transplantation , oncology , chemotherapy , biology , genetics
Plasmablastic lymphoma is a rare and aggressive malignancy strongly associated with HIV infection. The refractory/relapsed disease rate is high, and the survival rate is characteristically poor. There are no satisfactory salvage regimens for relapsed cases. We successfully performed autologous stem cell transplantation using a regimen consisting of MCNU (ranimustine), etoposide, cytarabine, and melphalan in a Japanese patient with relapsed AIDS-related plasmablastic lymphoma of the oral cavity. Highly active antiretroviral therapy continued during the therapy. Therapy-related toxicity was tolerable, and a total of 40 Gy of irradiation was administered after autologous stem cell transplantation. The patient has remained in complete remission for 16 months since transplantation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom